AMWL vs PATH · rev $254.4M vs P/E 19, rev $1.61B
American Well Corp (AMWL) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
American Well Corp (AMWL) is a health information services company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AMWL revenue for 2024-12-31 was $254.4M. Net income was -$212.6M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. AMWL currently screens at market cap $132.8M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AMWL currently screens at market cap $132.8M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AMWL and PATH stock pages for the full models.
Not investment advice.